Zymergen: Zymergen Ch. 11 Plan Confirmed After Investor Objection
Biotechnology company Zymergen received confirmation of its Chapter 11 plan Monday at a hearing in Delaware bankruptcy court after resolving an objection to the plan from a class of investors suing the company.
Read full article »
Zymergen is a California-based biotechnology company that designs and produces molecules, microbes and materials for agriculture, packaging and manufacturing industries.
Read more